The effect of an insulin releasing agent, BTS 67 582, on advanced glycation end product formation in vitro
References (25)
Am. J. Clin. Nutr.
(1993)- et al.
Diabet. Res. Clin. Proc.
(1993) - et al.
J. Biol. Chem.
(1995) - et al.
Crit. Rev. Food Sci. Nutr.
(1994) J. Clin. Lab. Anal.
(1993)- et al.
Science
(1986) - et al.
Br. J. Pharmacol.
(1997) - et al.
Diabetes Care
(1997) - et al.
Diabetes
(1992) - et al.
J. Clin. Invest.
(1991)
Biometrics
(1972)
Cited by (1)
Current therapies and emerging targets for the treatment of diabetes
2001, Current Pharmaceutical Design
- ∗
Annemarie Simpson, Knoll Pharmaceuticals, Biology, Research and Development, Pennyfoot Street, NOTTINGHAM, NG1 1GF. Tel: 0115 912 4215; FAX: 0115 912 4169.
Copyright © 1999 Published by Elsevier Inc.